Merit Medical Systems | MMSI - Umsatzerlöse

Aktienkurs
68.26
Täglich Wechseln
-0.39 -0.57%
Monatlich
-2.60%
Jährlich
-25.84%
Q2 Prognose
66.40




Der Umsatz Veränderung Datum
3M USD 6.1B 200M 2025-12
Abbott USD 11.46B 90M 2025-12
AngioDynamics USD 79.43M 3.72M 2025-09
Anika Therapeutics USD 30.62M 2.8M 2025-12
AtriCure USD 140.5M 6.2M 2025-12
Baxter International USD 2.97B 130M 2025-12
Becton, Dickinson and Co. USD 5.3B 600M 2025-12
Boston Scientific USD 5.29B 220M 2025-12
Cooper Companies USD 1.02B 41.1M 2025-12
Dexcom USD 1.26B 50M 2025-12
Edwards Lifesciences USD 1.57B 20M 2025-12
Globus Medical USD 826.4M 57.4M 2025-12
Haemonetics USD 338.97M 11.97M 2025-12
Hologic USD 1.05B 0 2025-12
ICU Medical USD 540.7M 3.7M 2025-12
Insulet USD 783.8M 77.5M 2025-12
Integra LifeSciences USD 434.9M 32.84M 2025-12
J&J USD 24.6B 610M 2025-12
Medtronic USD 9B 39M 2026-01
Merit Medical Systems USD 393.9M 9.7M 2025-12
Olympus JPY 261.05B 13.21B 2025-12
Pfizer USD 17.58B 880M 2025-12
STAAR Surgical USD 239.4M 144.7M 2025-12
Stryker USD 7.2B 1.14B 2025-12
Surmodics USD 29.57M 355K 2025-06
Tandem Diabetes Care USD 290.4M 41.15M 2025-12
Teleflex USD 568.98M 344.02M 2025-12
Terumo JPY 296.63B 21.66B 2025-12
Zimmer Biomet Holdings USD 2.24B 240M 2025-12